These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 25270304)

  • 21. Effect of montelukast for treatment of asthma in cigarette smokers.
    Price D; Popov TA; Bjermer L; Lu S; Petrovic R; Vandormael K; Mehta A; Strus JD; Polos PG; Philip G
    J Allergy Clin Immunol; 2013 Mar; 131(3):763-71. PubMed ID: 23380218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Montelukast-associated Churg-Strauss vasculitis: another associated report.
    Black JG; Bonner JR; Boulware D; Andea AA
    Ann Allergy Asthma Immunol; 2009 Apr; 102(4):351-2. PubMed ID: 19441609
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparative study of budesonide inhalation suspension and montelukast in young children with mild persistent asthma.
    Szefler SJ; Baker JW; Uryniak T; Goldman M; Silkoff PE
    J Allergy Clin Immunol; 2007 Nov; 120(5):1043-50. PubMed ID: 17983871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety of using montelukast during pregnancy.
    Koren G; Sarkar M; Einarson A
    Can Fam Physician; 2010 Sep; 56(9):881-2. PubMed ID: 20841587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluticasone propionate/salmeterol combination compared with montelukast for the treatment of persistent asthma.
    Pearlman DS; White MV; Lieberman AK; Pepsin PJ; Kalberg C; Emmett A; Bowers B; Rickard KA; Dorinsky P
    Ann Allergy Asthma Immunol; 2002 Feb; 88(2):227-35. PubMed ID: 11868930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Montelukast reduces asthma exacerbations in 2- to 5-year-old children with intermittent asthma.
    Bisgaard H; Zielen S; Garcia-Garcia ML; Johnston SL; Gilles L; Menten J; Tozzi CA; Polos P
    Am J Respir Crit Care Med; 2005 Feb; 171(4):315-22. PubMed ID: 15542792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A subgroup analysis of the MONICA study: a 12-month, open-label study of add-on montelukast treatment in asthma patients.
    Virchow JC; Mehta A; Ljungblad L; Mitfessel H
    J Asthma; 2010 Nov; 47(9):986-93. PubMed ID: 20858152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improving asthma control in patients suboptimally controlled on inhaled steroids and long-acting beta2-agonists: addition of montelukast in an open-label pilot study.
    Dupont L; Potvin E; Korn D; Lachman A; Dramaix M; Gusman J; Peché R;
    Curr Med Res Opin; 2005 Jun; 21(6):863-9. PubMed ID: 15969886
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antidepressant medication dispensing among montelukast initiators.
    Zhou EH; Kaplan S; Mosholder A; Moeny D; Ding Y; Wu Y; Iyasu S; Hammad TA
    J Asthma; 2013 Nov; 50(9):990-5. PubMed ID: 23841530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [What is the role of montelukast in asthma treatment?].
    Aksu K; Aksu F
    Tuberk Toraks; 2020 Sep; 68(3):328-330. PubMed ID: 33295731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A fixed combination of fluticasone and salmeterol permits better control of asthma than a beclomethasone dipropionate and montelukast combination].
    Grosclaude M; Cerruti JL; Delannay B; Hérent M; Spilthooren F; Desfougères JL
    Eur Ann Allergy Clin Immunol; 2003 Nov; 35(9):356-62. PubMed ID: 14716965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Steroid naive eosinophilic asthma: anti-inflammatory effects of fluticasone and montelukast.
    Jayaram L; Pizzichini E; Lemière C; Man SF; Cartier A; Hargreave FE; Pizzichini MM
    Thorax; 2005 Feb; 60(2):100-5. PubMed ID: 15681495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of behavior-related adverse experiences in clinical trials of montelukast.
    Philip G; Hustad CM; Malice MP; Noonan G; Ezekowitz A; Reiss TF; Knorr B
    J Allergy Clin Immunol; 2009 Oct; 124(4):699-706.e8. PubMed ID: 19815116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of fluticasone propionate and salmeterol in a single device, fluticasone propionate, and montelukast on overall asthma control, exacerbations, and costs.
    O'Connor RD; Stanford R; Crim C; Yancey SW; Edwards L; Rickard KA; Dorinsky P
    Ann Allergy Asthma Immunol; 2004 Dec; 93(6):581-8. PubMed ID: 15609769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Montelukast and airway remodeling in children with chronic persistent asthma: an open study.
    Pifferi M; Caramella D; Ragazzo V; De Marco E; Pietrobelli A; Boner AL
    Pediatr Allergy Immunol; 2004 Oct; 15(5):472-3. PubMed ID: 15482525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of fluticasone propionate-salmeterol combination therapy and montelukast in patients who are symptomatic on short-acting beta(2)-agonists alone.
    Calhoun WJ; Nelson HS; Nathan RA; Pepsin PJ; Kalberg C; Emmett A; Rickard KA; Dorinsky P
    Am J Respir Crit Care Med; 2001 Sep; 164(5):759-63. PubMed ID: 11549529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety, tolerability, and exploratory efficacy of montelukast in 6- to 24-month-old patients with asthma.
    van Adelsberg J; Moy J; Wei LX; Tozzi CA; Knorr B; Reiss TF
    Curr Med Res Opin; 2005 Jun; 21(6):971-9. PubMed ID: 15969897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploring the possible association between montelukast and neuropsychiatric events among children with asthma: a matched nested case-control study.
    Ali MM; O'Brien CE; Cleves MA; Martin BC
    Pharmacoepidemiol Drug Saf; 2015 Apr; 24(4):435-45. PubMed ID: 25683909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Observational study of the effects of using montelukast vs fluticasone in patients matched at baseline.
    Allen-Ramey FC; Duong PT; Riedel AA; Markson LE; Weiss KB
    Ann Allergy Asthma Immunol; 2004 Oct; 93(4):373-80. PubMed ID: 15521374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma.
    Szefler SJ; Phillips BR; Martinez FD; Chinchilli VM; Lemanske RF; Strunk RC; Zeiger RS; Larsen G; Spahn JD; Bacharier LB; Bloomberg GR; Guilbert TW; Heldt G; Morgan WJ; Moss MH; Sorkness CA; Taussig LM
    J Allergy Clin Immunol; 2005 Feb; 115(2):233-42. PubMed ID: 15696076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.